Table 1 Anthropometric and clinical data of all patients. Women in Group A received r-FSH + r-LH/2:1, those in Group B hMG. Data are expressed as mean ± SD or as percentage
Group A | Group B | p | |
|---|---|---|---|
Number of patients | 398 | 450 | |
Age (yrs) | 36.7 ± 4.0 | 36.8 ± 4.1 | ns |
BMI | 22.6 ± 3.6 | 22.0 ± 3.1 | ns |
Basal (day 3) FSH (IU/l) | 8.1 ± 3.3 | 8.1 ± 3.2 | ns |
Antral Follicle Count (AFC) | 9.9 ± 6.2 | 10.3 ± 6.7 | ns |
Main infertility cause (%) | ns | ||
Anovulation | 1 | 2 | |
Endometriosis | 11 | 8 | |
Male | 44 | 51 | |
Tubal | 16 | 13 | |
Unexplained | 17 | 17 | |
Mixed | 11 | 9 | |
Smoke habit (%) | 16.3 | 20.2 | ns |
Total Gonadotropin dose (IU) | 2705 ± 1598 | 2837 ± 1171 | ns |
Peak E2 (pg/ml) | 2644 ± 1117 | 2303 ± 990 | ns |
Retrieved oocytes/patient | 6.7 ± 4.2 | 6.1 ± 4.1 | ns |
MII oocytes/patient | 4.3 ± 2.7 | 4.2 ± 2.3 | ns |
Embryo morphological score | 6.1 ± 3.6 | 6.2 ± 3.6 | ns |
Top scored (>8/10) embryos (%) | 21 | 20 | ns |
Number of transferred embryos | 2.0 ± 0.1 | 2.0 ± 0.1 | ns |
Endometrial thickness (mm) | 10.8 ± 2.3 | 10.6 ± 2.2 | ns |